Skip to main content
. 2015 Dec 30;36:225–233. doi: 10.1007/s40261-015-0372-9
Of patients newly initiated on statin treatment, one-fifth experienced a decrease in HDL-C.
This HDL-C decrease was associated with higher risk of major adverse cardiovascular events compared with unchanged HDL-C.
Statin induced HDL-C decrease might be more hazardous than previously recognised and patients should be monitored closely regarding potential cardiovascular risk.